The FDA has approved Gvoke VialDx (glucagon) for IV use as a diagnostic aid during radiologic examinations to temporarily inhibit movement of the GI tract.

Merck’s new formulation of the mega-blockbuster Keytruda, made in collaboration with Alteogen, could help to keep the drug’s ...

Merck will partner with Chinese biotech Abbisko Therapeutics to market and sell the bone-tumor treatment pimicotinib globally, expanding its commercialization rights for the drug beyond Asia. The ...

Merck & Co said on Thursday that it plans to launch a subcutaneously injected version of its blockbuster cancer immunotherapy ...

Novo Nordisk is taking aim at Eli Lilly with a new obesity drug deal. Meanwhile, a survey shows doctors’ perception of the ...

Merck & Co. is handing over $200 million to China’s Hengrui Pharma for a phase 2-stage lipoprotein(a) (Lp(a)) inhibitor.

Merck joins a growing list of companies targeting lipoprotein(a), high levels of which are associated with an elevated risk ...

Read the Market Summary Here:- https://reportocean.com/industry-verticals/sample-request?report_id=bw8540 ...

While antiretroviral treatment can improve immune function, leading to fewer GI symptoms, this could be counterbalanced by adverse GI toxicity profiles from certain antiretrovirals. Ritonavir ...

Merck & Co has ended a second phase 3 trial of its Alzheimer’s drug, verubecestat, after an interim analysis found that it was unlikely to succeed in slowing the progression of the disease in ...

(Reuters/Eloisa Lopez) MANILA — Former Philippine President Rodrigo Duterte was arrested and taken into custody on Tuesday in Manila on an International Criminal Court warrant for the “war on drugs” ...

Merck has opened a $1 billion, 225,000-square-foot facility at its Durham campus dedicated to vaccine manufacturing, the drug giant announced Tuesday. Merck has opened a $1 billion, 225,000-square ...